Article Information
History
- March 5, 2025.
Article Versions
- You are currently viewing Version 1 of this article (March 5, 2025 - 21:15).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Cole Maguire1,
- Kristina Kashyap2,
- Elizabeth Williams1,
- Aziz Rija2,
- Maisey Schuler3,
- Cheyenne Ahamed2,
- Chumeng Wang1,
- Aurelia Mena2,
- Jeffrey Saniuk2,
- Johanna Busch2,
- Sara Austin2,
- Mary Kelley1,
- W. Michael Brode2 and
- Esther Melamed1,4 (esther.melamed{at}austin.utexas.edu)
- 1 Department of Neurology, The University of Texas at Austin, Dell Medical School, Austin, TX, USA;
- 2 Department of Internal Medicine, The University of Texas at Austin, Dell Medical School, Austin, TX, USA;
- 3 The University of Michigan Medical School, Ann Arbor, MI, USA
- ↵* Corresponding author; email: esther.melamed{at}austin.utexas.edu
Posted March 05, 2025.
Analysis of 977 Long COVID Patients Reveals Prevalent Neuropathy and Association with Anti-Ganglioside Antibodies
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos